Intermediate-risk (submassive) pulmonary embolism (PE) describes normotensive patients
with evidence of right ventricular compromise, whereas high-risk (massive) PE comprises …

Background To examine whether venoarterial extracorporeal membrane oxygenation (VA-
ECMO) improves survival of patients with acute pulmonary embolism (PE). Methods …

Aim of the study Extracorporeal membrane oxygenation (ECMO) is considered a life-saving
treatment option for patients in cardiogenic shock or cardiac arrest undergoing …

Acute pulmonary embolism (PE) leads to an abrupt increase in pulmonary vascular
resistance and right ventricular afterload, and when significant enough, can result in …

Отказ от ответственности. Рекомендации ЕАК отражают точку зрения ЕАК и были
подготовлены после тщательного изучения научных и медицинских данных …

Acute pulmonary embolism (PE) affects over 600,000 Americans per year and is a common
diagnostic consideration among emergency department patients. Although there are well …

Thanks to advances in interventional cardiology technologies, catheter-directed treatment
has become recently a viable therapeutic option in the treatment of patients with acute …

Objective To investigate the trend and outcomes of acute pulmonary embolism (PE) during
pregnancy and puerperium using a large national database. Patients and Methods The …

Aims There is limited data on the association between hospital catheter-directed intervention
(CDI) volume and outcomes among patients with acute pulmonary embolism (PE). Methods …

Venoarterial extracorporeal membrane oxygenation (ECMO) has been used to treat acute
massive pulmonary embolism (PE) patients. However, the incremental benefit of ECMO to …